In Between the Light and the Dark: Developments in Photosensitive Pharmaceuticals

A structured, risk-based framework for pharmaceutical compounding that enhances quality, regulatory compliance, and process consistency.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Delayed cerebral ischemia is a leading complication in the severe form of stroke known as subarachnoid hemorrhage and can result in long-term neurological damage, disability, or death.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

The company estimated that more than 1000 women in Scotland at very high risk of fracture would be eligible for treatment.

Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise.